Otsuka Pharmaceutical
Otsuka Pharmaceutical Co., Ltd., commonly referred to as Otsuka, is a leading global healthcare company headquartered in Japan. Established in 1964, Otsuka has made significant strides in the pharmaceutical and nutraceutical industries, focusing on innovative solutions for mental health, oncology, and general healthcare. With a strong presence in regions such as North America, Europe, and Asia, Otsuka is renowned for its unique products, including the antipsychotic medication Abilify and the hydration solution Pocari Sweat. The company’s commitment to research and development has positioned it as a pioneer in addressing unmet medical needs. Otsuka's dedication to innovation and patient care has earned it a notable reputation in the global market, making it a key player in the pharmaceutical landscape.
DitchCarbon Score
How does Otsuka Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Otsuka Pharmaceutical's score of 30 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Otsuka Pharmaceutical's reported carbon emissions
In 2023, Otsuka Pharmaceutical reported total carbon emissions of approximately 523,000,000 kg CO2e, comprising 327,309,000 kg CO2e from Scope 1 and 195,362,000 kg CO2e from Scope 2. The company has set ambitious climate commitments, aiming to achieve a 30% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2030, using 2017 as the base year. Additionally, Otsuka targets a 20% reduction in absolute Scope 3 emissions by the same year. Otsuka's long-term vision includes a commitment to reach "Net Zero" emissions by 2050, with initiatives to integrate energy services across all business activities. The company is actively working towards reducing its environmental impact and aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2011 | 2012 | 2017 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 285,728,000 | 000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 116,816,000 | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | 402,544,000 | 000,000,000 | - | - | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Otsuka Pharmaceutical is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
